Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study.

@article{Wang2015HaploidenticalVI,
  title={Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study.},
  author={Yu Wang and Qifa Liu and Lanping Xu and Kaiyan Liu and Xiao-Hui Zhang and Xiao Ma and Zhi-ping Fan and Depei Wu and Xiaojun Huang},
  journal={Blood},
  year={2015},
  volume={125 25},
  pages={3956-62}
}
The effects of HLA-identical sibling donor (ISD) hematopoietic stem cell transplantation (HSCT) on adults with intermediate- or high-risk acute myeloid leukemia (AML) in the first complete remission (CR1) are well established. Previous single-center studies have demonstrated similar survival after unmanipulated haploidentical donor (HID) vs ISD HSCT for hematologic malignancies. To test the hypothesis that haploidentical HSCT would be a valid option as postremission therapy for AML patients in… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 59 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Long - term follow - up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia : nine years of experience at a single center

  • KY Liu
  • Cancer
  • 2013

Acute myeloid leukemia. NCCN practice guidelines in oncology version 2.2011

  • Members NAMLP
  • http://www.docin.com/p-220085937.html. Accessed…
  • 2012

Similar Papers

Loading similar papers…